Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Frontiers in Pharmacology
|
January 3, 2022
UDCA Inhibits Hypoxic Hepatocellular Carcinoma Cell-Induced Angiogenesis Through Suppressing HIF-1α/VEGF/IL-8 Intercellular Signaling
Wanfu Lin, Shu Li, Yongbin Meng, et al.
Journal of Ethnopharmacology
|
February 19, 2025
Paeoniflorin inhibits chronic restraint stress-induced progression of hepatocellular carcinoma through suppressing norepinephrine-induced activation of hepatic stellate cells via SRC/AKT/ERK pathways
Yujun Luo, Wanfu Lin, Shuang Xiang, et al.
Bioorganic Chemistry
|
March 6, 2025
Discovery of bifunctional small molecules targeting PD-L1/VISTA with favorable pharmacokinetics for cancer immunotherapy
Yao Xiao, Yaru Shi, Chuxiao Shao, et al.
Oncology Reports
|
August 2, 2018
Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma
Dong Liu, Yifu Fan, Jun Li, et al.
Arthritis Research & Therapy
|
June 3, 2014
Ginsenoside Rh1 potentiates dexamethasone's anti-inflammatory effects for chronic inflammatory disease by reversing dexamethasone-induced resistance
Jun Li, Juan Du, Dong Liu, et al.
Cell Death & Disease
|
May 3, 2025
Comprehensive secretome profiling and CRISPR screen identifies SFRP1 as a key inhibitor of epidermal progenitor proliferation
Binbin Cheng, Shaohong Isaac Peng, Yunlong Y Jia, et al.
Journal of Advanced Research
|
November 27, 2025
Spop-binding bifunctional degraders: a novel approach for cancer immunotherapy
Binbin Cheng, Zhihua Kong, Yaru Shi, et al.
International Immunopharmacology
|
October 10, 2025
Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosis
Shufang Liang, Guokai Huang, Meihuan Fu, et al.
Journal of Ethnopharmacology
|
May 1, 2026
Diosgenin alleviates hepatic fibrosis via PI3K/Akt/mTOR mediated fatty acid metabolic reprogramming and NF-κB activation
Yuanrong Shi, Ye Zhang, Dan Liu, et al.
European Journal of Medicinal Chemistry
|
July 3, 2024
Recent progress in the development of hypoxia-inducible factor 2α (HIF-2α) modulators: Inhibitors, agonists, and degraders (2009-2024)
Binbin Cheng, Xianshi Ma, Yingxing Zhou, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Frontiers in Pharmacology
|
January 3, 2022
UDCA Inhibits Hypoxic Hepatocellular Carcinoma Cell-Induced Angiogenesis Through Suppressing HIF-1α/VEGF/IL-8 Intercellular Signaling
Wanfu Lin, Shu Li, Yongbin Meng, et al.
Journal of Ethnopharmacology
|
February 19, 2025
Paeoniflorin inhibits chronic restraint stress-induced progression of hepatocellular carcinoma through suppressing norepinephrine-induced activation of hepatic stellate cells via SRC/AKT/ERK pathways
Yujun Luo, Wanfu Lin, Shuang Xiang, et al.
Bioorganic Chemistry
|
March 6, 2025
Discovery of bifunctional small molecules targeting PD-L1/VISTA with favorable pharmacokinetics for cancer immunotherapy
Yao Xiao, Yaru Shi, Chuxiao Shao, et al.
Oncology Reports
|
August 2, 2018
Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma
Dong Liu, Yifu Fan, Jun Li, et al.
Arthritis Research & Therapy
|
June 3, 2014
Ginsenoside Rh1 potentiates dexamethasone's anti-inflammatory effects for chronic inflammatory disease by reversing dexamethasone-induced resistance
Jun Li, Juan Du, Dong Liu, et al.
Cell Death & Disease
|
May 3, 2025
Comprehensive secretome profiling and CRISPR screen identifies SFRP1 as a key inhibitor of epidermal progenitor proliferation
Binbin Cheng, Shaohong Isaac Peng, Yunlong Y Jia, et al.
Journal of Advanced Research
|
November 27, 2025
Spop-binding bifunctional degraders: a novel approach for cancer immunotherapy
Binbin Cheng, Zhihua Kong, Yaru Shi, et al.
International Immunopharmacology
|
October 10, 2025
Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosis
Shufang Liang, Guokai Huang, Meihuan Fu, et al.
Journal of Ethnopharmacology
|
May 1, 2026
Diosgenin alleviates hepatic fibrosis via PI3K/Akt/mTOR mediated fatty acid metabolic reprogramming and NF-κB activation
Yuanrong Shi, Ye Zhang, Dan Liu, et al.
European Journal of Medicinal Chemistry
|
July 3, 2024
Recent progress in the development of hypoxia-inducible factor 2α (HIF-2α) modulators: Inhibitors, agonists, and degraders (2009-2024)
Binbin Cheng, Xianshi Ma, Yingxing Zhou, et al.
Page
of 10